デフォルト表紙
市場調査レポート
商品コード
1587802

ADME毒性試験の市場規模、シェア、動向分析レポート:技術別、用途別、手法別、地域別、セグメント予測、2025年~2030年

ADME Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture Tech, High Throughput Tech, Molecular Imaging), By Application, By Method, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ADME毒性試験の市場規模、シェア、動向分析レポート:技術別、用途別、手法別、地域別、セグメント予測、2025年~2030年
出版日: 2024年10月15日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ADME毒性試験市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、ADME毒性試験の世界市場規模は2025年から2030年にかけてCAGR 10.0%で拡大し、2030年には114億4,000万米ドルに達する見込みです。

製薬企業によるより適切な毒性試験法の採用により、後期段階の薬剤の失敗をチェックする必要性が高まっていることなどが、同市場の収益創出を後押しすると期待されています。

吸収・分布・代謝・排泄(ADME)毒性試験は、化学的、薬学的、遺伝的などの要因や全身反応について、臨床試験で分子が引き起こす毒性反応を試験するために使用されます。このような毒物学的試験手順は、投与時の体内毒性反応を制限または予防する効果的な医薬品開発に役立ちます。毒性レベルは、薬物と宿主との間のほぼリアルタイムの反応を表す、自然に近い条件下で実施される一連の試験の結果に基づいて決定されます。

2017年現在、ADME毒性試験分野の約43.0%が細胞培養技術に基づいて実施されています。細胞培養技術は、自然に近い条件や細胞レベルで得られる正確な結果などの利点により、広く採用されています。

これらのアッセイは、いくつかのタイプの毒性反応または毒性反応が起こる可能性のある系に対して実施されます。毒性試験の中には、全身毒性、腎毒性、肝毒性、神経毒性、その他生体組織で生じる可能性のある毒性などがあります。試験方法の動向は現在進行中であり、この動向は薬剤分子を開発する多くの企業が取り上げることになると思われます。これは創薬プロセスを加速し、市場の成長を後押しすると思われます。

ADME毒性試験市場のレポートハイライト

  • 後期段階での医薬品失敗の割合が増加し、医薬品開発のための貴重な時間と投資が失われることが市場を牽引しています。また、OMICS技術の成長と採用の増加が、今後数年間の収益創出を押し上げると予想されます。
  • 北米は、多数の製薬会社が新規分子の商業的上市を目指して競争しているため、ADME毒性試験の最大市場となっています。
  • アジア太平洋とラテンアメリカの新興国市場は、多くの多国籍企業や地元企業が市場への参入を目指しているため、大きく成長する見込みです。また、イノベーションと成長機会のある市場での地位向上を目指しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 ADME毒性試験市場:技術ビジネス分析

  • セグメントダッシュボード
  • 世界のADME毒性試験市場の変動分析
  • 世界のADME毒性試験市場規模と動向分析、技術別、2018年から2030年
  • 細胞培養技術
  • ハイスループット技術
  • 分子イメージング
  • オミックス技術

第5章 ADME毒性試験市場:手法ビジネス分析

  • セグメントダッシュボード
  • 世界のADME毒性試験市場の変動分析
  • 世界のADME毒性試験市場の規模と動向分析、手法別、2018年から2030年
  • 細胞アッセイ
  • 生化学分析
  • シミュレーション
  • 生体外

第6章 ADME毒性試験市場:用途ビジネス分析

  • セグメントダッシュボード
  • 世界のADME毒性試験市場の変動分析
  • 世界のADME毒性試験市場の規模と動向分析、用途別、2018年から2030年
  • 全身毒性
  • 腎毒性
  • 肝毒性
  • 神経毒性
  • その他

第7章 ADME毒性試験市場:技術、手法、用途別の地域推定・動向分析

  • 地域市場ダッシュボード
  • 市場規模と予測および動向分析、2018年から2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参入企業
  • 企業市況分析、2024年
  • 参入企業の概要
    • Thermo Fisher Scientific Inc.
    • Danaher
    • Charles River Laboratories
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Curia Global, Inc.
    • Dassault Systemes
    • Catalent, Inc
    • Labcorp
    • Eurofins Scientific
    • Miltenyi Biotec
    • IQVIA Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 4 Global ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 5 Global ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 6 Global ADME toxicology testing market, by region, 2018 - 2030 (USD million)
  • Table 7 North America ADME toxicology testing market, by country, 2018 - 2030 (USD million)
  • Table 8 North America ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 9 North America ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 10 North America ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 11 U.S. ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 12 U.S. ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 13 U.S. ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 14 Canada ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 15 Canada ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 16 Canada ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 17 Mexico ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 18 Mexico ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 19 Mexico ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 20 Europe ADME toxicology testing market, by country, 2018 - 2030 (USD million)
  • Table 21 Europe ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 22 Europe ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 23 Europe ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 24 UK ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 25 UK ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 26 UK ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 27 Germany ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 28 Germany ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 29 Germany ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 30 France ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 31 France ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 32 France ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 33 Italy ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 34 Italy ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 35 Italy ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 36 Spain ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 37 Spain ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 38 Spain ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 39 Denmark ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 40 Denmark ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 41 Denmark ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 42 Sweden ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 43 Sweden ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 44 Sweden ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 45 Norway ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 46 Norway ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 47 Norway ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 48 Asia Pacific ADME toxicology testing market, by country, 2018 - 2030 (USD million)
  • Table 49 Asia Pacific ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 50 Asia Pacific ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 51 Asia Pacific ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 52 Japan ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 53 Japan ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 54 Japan ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 55 China ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 56 China ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 57 China ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 58 India ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 59 India ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 60 India ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 61 Australia ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 62 Australia ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 63 Australia ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 64 Thailand ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 65 Thailand ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 66 Thailand ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 67 South Korea ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 68 South Korea ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 69 South Korea ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 70 Latin America ADME toxicology testing market, by country, 2018 - 2030 (USD million)
  • Table 71 Latin America ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 72 Latin America ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 73 Latin America ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 74 Brazil ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 75 Brazil ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 76 Brazil ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 77 Argentina ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 78 Argentina ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 79 Argentina ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 80 Middle East & Africa ADME toxicology testing market, by country, 2018 - 2030 (USD million)
  • Table 81 Middle East & Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 82 Middle East & Africa ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 83 Middle East & Africa ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 84 South Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 85 South Africa ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 86 South Africa ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 87 Saudi Arabia ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 88 Saudi Arabia ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 89 Saudi Arabia ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 90 UAE ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 91 UAE ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 92 UAE ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 93 Kuwait ADME toxicology testing market, by technology, 2018 - 2030 (USD million)
  • Table 94 Kuwait ADME toxicology testing market, by method, 2018 - 2030 (USD million)
  • Table 95 Kuwait ADME toxicology testing market, by application, 2018 - 2030 (USD million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 ADME toxicology testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 ADME toxicology testing market driver analysis
  • Fig. 12 ADME toxicology testing market restraint analysis
  • Fig. 13 ADME toxicology testing market: Porter's analysis
  • Fig. 14 ADME toxicology testing market: PESTEL analysis
  • Fig. 15 ADME toxicology testing market: Technology outlook and key takeaways
  • Fig. 16 ADME toxicology testing market: Technology market share analysis, 2024 & 2030
  • Fig. 17 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 High throughput market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Molecular imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 OMICS technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 ADME toxicology testing market: Method outlook and key takeaways
  • Fig. 22 ADME toxicology testing market: Method market share analysis, 2024 & 2030
  • Fig. 23 Cellular assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Biochemical assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 In-silica market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Ex-vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 ADME toxicology testing market: Application outlook and key takeaways
  • Fig. 28 ADME toxicology testing market: Application market share analysis, 2024 & 2030
  • Fig. 29 Systemic toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Renal toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Hepatotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Neurotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Other toxicities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Canada ADME toxicology testing market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 39 Europe ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 40 UK ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 41 Germany ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 42 France ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 43 Italy ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 44 Spain ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 45 Denmark ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 46 Sweden ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 47 Norway ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 48 Asia Pacific ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 49 Japan ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 50 China ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 51 India ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Australia ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 53 Thailand ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 54 South Korea ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 55 Latin America ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 56 Brazil ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 57 Argentina ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 58 MEA ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 59 South Africa ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 60 Saudi Arabia ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 61 UAE ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 62 Kuwait ADME toxicology testing market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 Key company categorization
  • Fig. 64 Company market positioning
  • Fig. 65 Market participant categorization
  • Fig. 66 Strategy framework
目次
Product Code: GVR-2-68038-627-1

ADME Toxicology Testing Market Growth & Trends:

The global ADME toxicology testing market size is expected to reach USD 11.44 billion by 2030, expanding at a CAGR of 10.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.

Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near-natural conditions, which represent almost real-time reactions between the drug and the host.

As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near-natural conditions and accurate results obtained at a cellular level.

These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost the market growth.

ADME Toxicology Testing Market Report Highlights:

  • The market is driven by an increasing ratio of late-stage drug failures, resulting in loss of valuable time and investment for drug development. Growth and increasing adoption of OMICS technology is also expected to boost revenue generation in the coming years
  • North America is the largest market for ADME toxicology testing owing to the presence of a large number of pharmaceutical companies competing for the commercial launch of novel molecules
  • Developing regions of Asia Pacific and Latin America are set to grow considerably as many multinational and local players are striving to enter the market. They are also looking to improve their hold in markets that present innovation and growth opportunities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Method
    • 1.2.3. Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High rate of late-stage drug failure
      • 3.2.1.2. Increasing need for novel drug molecules
      • 3.2.1.3. Technological advancements in ADME studies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges pertaining to in vitro ADME studies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. ADME Toxicology Testing Market: Technology Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global ADME Toxicology Testing Market Movement Analysis
  • 4.3. Global ADME Toxicology Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Cell Culture Tech
    • 4.4.1. Global Cell Culture Tech Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. High Throughput Tech
    • 4.5.1. Global High Throughput Tech Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Molecular Imaging
    • 4.6.1. Global Molecular Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. OMICS Tech
    • 4.7.1. Global OMICS Tech Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. ADME Toxicology Testing Market: Method Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global ADME Toxicology Testing Market Movement Analysis
  • 5.3. Global ADME Toxicology Testing Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 5.4. Cellular Assay
    • 5.4.1. Global Cellular Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biochemical Assay
    • 5.5.1. Global Biochemical Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. In Silico
    • 5.6.1. Global In Silico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Ex-vivo
    • 5.7.1. Global Ex-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. ADME Toxicology Testing Market: Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global ADME Toxicology Testing Market Movement Analysis
  • 6.3. Global ADME Toxicology Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Systemic Toxicity
    • 6.4.1. Global Systemic Toxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Renal Toxicity
    • 6.5.1. Global Renal Toxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Hepatotoxicity
    • 6.6.1. Global Hepatotoxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Neurotoxicity
    • 6.7.1. Global Neurotoxicity Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. ADME Toxicology Testing Market: Regional Estimates & Trend Analysis by Technology, Method, & Application

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait ADME Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Overview
      • 8.3.1.2. Product Benchmarking
      • 8.3.1.3. Strategic Initiatives
    • 8.3.2. Danaher
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Charles River Laboratories
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Promega Corporation
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Agilent Technologies, Inc.
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Curia Global, Inc.
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Dassault Systemes
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Catalent, Inc
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Labcorp
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Eurofins Scientific
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Miltenyi Biotec
      • 8.3.11.1. Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. IQVIA Inc.
      • 8.3.12.1. Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives